radiopharmaceutical therapy

You have access
Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose ²¹¹At-Labeled Anti-HER2 Single-Domain Antibody Fragment
Yutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Stephen Jannetti, Ganesan Vaidyanathan and Michael R. Zalutsky

Journal of Nuclear Medicine January 1, 2023, 64 (1) 124-130; DOI: https://doi.org/10.2967/jnumed.122.264071
You have access
A Realistic Multi-region Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy
Clarita Saldarriaga Vargas, Lara Struelens, Matthias D'Huyvetter, Vicky Caveliers and Peter Covens

Journal of Nuclear Medicine October 13, 2022, jnumed.122.264453; DOI: https://doi.org/10.2967/jnumed.122.264453
You have access
SIR-Spheres Activity Measurements Reveal Systematic Miscalibration
Stephen A. Graves, Molly Martin, Ashok Tiwari, Michael Merrick and John Sunderland

Journal of Nuclear Medicine August 1, 2022, 63 (8) 1131-1135; DOI: https://doi.org/10.2967/jnumed.121.262650
You have access
An Improved ²¹¹At-Labeled Agent for PSMA-Targeted α-Therapy
Ronnie C. Mease, Choong Mo Kang, Vivek Kumar, Sangeeta Ray Banerjee, Il Minn, Mary Brummet, Kathleen L. Gabrielson, Yutian Feng, Andrew Park, Ana P. Kiess, George Sgouros, Ganesan Vaidyanathan, Michael R. Zalutsky and Martin G. Pomper

Journal of Nuclear Medicine February 1, 2022, 63 (2) 259-267; DOI: https://doi.org/10.2967/jnumed.121.262098
You have access
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
George Sgouros, Yuni K. Dewaraja, Freddy Escorcia, Stephen A. Graves, Thomas A. Hope, Amir Iravani, Neeta Pandit-Taskar, Babak Saboury, Sara St. James and Pat B. Zanzonico

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 12S-22S; DOI: https://doi.org/10.2967/jnumed.121.262750
You have access
Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
Jacek Capala, Stephen A. Graves, Aaron Scott, George Sgouros, Sara St. James, Pat Zanzonico and Brian E. Zimmerman

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 3S-11S; DOI: https://doi.org/10.2967/jnumed.121.262749
You have access
Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice
Neeta Pandit-Taskar, Amir Iravani, Dan Lee, Heather Jacene, Dan Pryma, Thomas Hope, Babak Saboury, Jacek Capala and Richard L. Wahl

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 60S-72S; DOI: https://doi.org/10.2967/jnumed.121.262977
You have access
Landscape Analysis of Phase 2 and 3 Clinical Trials for Targeted Radionuclide Therapy
Erik Mittra and Lisa Bodei

Journal of Nuclear Medicine August 1, 2021, 62 (8) 1031-1032; DOI: https://doi.org/10.2967/jnumed.120.258103
You have access
Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies
Xinchi Hou, Julia Brosch, Carlos Uribe, Alessandro Desy, Guido Böning, Jean-Mathieu Beauregard, Anna Celler and Arman Rahmim

Journal of Nuclear Medicine July 1, 2021, 62 (7) 1006-1011; DOI: https://doi.org/10.2967/jnumed.120.254656
You have access
Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
Richard L. Wahl, Panithaya Chareonthaitawee, Bonnie Clarke, Alexander Drzezga, Liza Lindenberg, Arman Rahmim, James Thackeray, Gary A. Ulaner, Wolfgang Weber, Katherine Zukotynski and John Sunderland

Journal of Nuclear Medicine January 1, 2021, 62 (1) 6-14; DOI: https://doi.org/10.2967/jnumed.120.253450

Main menu

User menu

Search

radiopharmaceutical therapy

Pages